1. Home
  2. FATE vs TSQ Comparison

FATE vs TSQ Comparison

Compare FATE & TSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FATE
  • TSQ
  • Stock Information
  • Founded
  • FATE 2007
  • TSQ 1996
  • Country
  • FATE United States
  • TSQ United States
  • Employees
  • FATE N/A
  • TSQ 2159
  • Industry
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • TSQ Broadcasting
  • Sector
  • FATE Health Care
  • TSQ Consumer Discretionary
  • Exchange
  • FATE Nasdaq
  • TSQ Nasdaq
  • Market Cap
  • FATE 108.2M
  • TSQ 101.3M
  • IPO Year
  • FATE 2013
  • TSQ 2000
  • Fundamental
  • Price
  • FATE $1.28
  • TSQ $6.68
  • Analyst Decision
  • FATE Hold
  • TSQ Buy
  • Analyst Count
  • FATE 8
  • TSQ 1
  • Target Price
  • FATE $5.43
  • TSQ $15.00
  • AVG Volume (30 Days)
  • FATE 2.5M
  • TSQ 61.3K
  • Earning Date
  • FATE 05-08-2025
  • TSQ 05-08-2025
  • Dividend Yield
  • FATE N/A
  • TSQ 11.94%
  • EPS Growth
  • FATE N/A
  • TSQ N/A
  • EPS
  • FATE N/A
  • TSQ N/A
  • Revenue
  • FATE $13,631,000.00
  • TSQ $450,982,000.00
  • Revenue This Year
  • FATE N/A
  • TSQ N/A
  • Revenue Next Year
  • FATE N/A
  • TSQ $6.71
  • P/E Ratio
  • FATE N/A
  • TSQ N/A
  • Revenue Growth
  • FATE N/A
  • TSQ N/A
  • 52 Week Low
  • FATE $0.66
  • TSQ $6.58
  • 52 Week High
  • FATE $5.92
  • TSQ $12.92
  • Technical
  • Relative Strength Index (RSI)
  • FATE 60.93
  • TSQ 33.90
  • Support Level
  • FATE $1.02
  • TSQ $6.58
  • Resistance Level
  • FATE $1.49
  • TSQ $7.10
  • Average True Range (ATR)
  • FATE 0.17
  • TSQ 0.36
  • MACD
  • FATE 0.05
  • TSQ -0.02
  • Stochastic Oscillator
  • FATE 74.07
  • TSQ 9.17

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About TSQ Townsquare Media Inc.

Townsquare Media Inc is a radio, digital media, entertainment, and digital marketing solutions company principally focused on being the premier local advertising and marketing solutions platform in small and mid-sized markets across the United States. It has three segments which are Subscription Digital Marketing Solutions, Digital Advertising, and Broadcast Advertising. It earns the majority of the revenue from the Broadcasting Advertising segment, which includes its local, regional, and national advertising products and solutions delivered via terrestrial radio broadcast. Its portfolio includes local media brands such as WYRK.com, WJON.com, and NJ101.5.com, and premier national music brands such as XXLmag.com, TasteofCountry.com, UltimateClassicRock.com, and Loudwire.com.

Share on Social Networks: